Combination of radiation and razoxane (ICRF 159) in vivo
- PMID: 632139
- DOI: 10.1016/0360-3016(78)90124-4
Combination of radiation and razoxane (ICRF 159) in vivo
Similar articles
-
A clinical evaluation of ICRF 159 as a radiosensitising agent.Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):127-31. doi: 10.1016/0360-3016(78)90127-x. Int J Radiat Oncol Biol Phys. 1978. PMID: 344288 Clinical Trial. No abstract available.
-
Radiotherapy combined with ICRF 159 (NSC 129943).Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):121-6. doi: 10.1016/0360-3016(78)90126-8. Int J Radiat Oncol Biol Phys. 1978. PMID: 204615 No abstract available.
-
Further evaluation of bimolane and analogs as potential antitumor agents.Eur J Cancer Clin Oncol. 1985 Apr;21(4):493-7. doi: 10.1016/0277-5379(85)90043-4. Eur J Cancer Clin Oncol. 1985. PMID: 3859415
-
ICRF-187 in clinical oncology.Cancer Clin Trials. 1981;4(2):143-6. Cancer Clin Trials. 1981. PMID: 6788388 Review.
-
[Radio-oncological treatment possibilities in local recurrence of rectal carcinoma. An interdisciplinary comparison].Wien Med Wochenschr. 1990 Apr 30;140(8):206-11. Wien Med Wochenschr. 1990. PMID: 2194376 Review. German.
Cited by
-
Antitumor effect of RA233 alone and combined with radiotherapy.Clin Exp Metastasis. 1983 Apr-Jun;1(2):181-90. doi: 10.1007/BF00121497. Clin Exp Metastasis. 1983. PMID: 6546197
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources